IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine

Experimental Oncology

Volumn 29, Issue 3, 2007, Pages 226-230

  Abramenko, I ^a   Bilous, N ^a   Kryachok, I ^a   Filonenko, I ^a   Pilipenko, G ^b   Chumak, A ^a   Bazyka, D ^a   Bebeshko, V ^a  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b Cherkassy Regional Oncology Dispancer ^*  (Ukraine)

Author keywords

Chronic lymphocytic leukemia; IGHV3 21; Immunoglobulin variable heavy chain gene; Prognostic factor

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN VARIABLE HEAVY CHAIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN MOTIF;

ADULT; AGED; AMINO ACID SEQUENCE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; UKRAINE;

EID: 36749045785     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004; 103: 4389-95.
2. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804-15.
3. Caligaris-Cappio F, Scielzo C, Camporeale A, Ghia P. Biology of chronic lymphocytic leukemia: new perspectives. Hematology 2005; 1: 192-5.
4. Stamatopoulos K, Belessi C, Moreno C, Boudiograh M, Guida G, Smilevska T, Belhoul L, Stella S, Stavroyianni N, Crespo M, Hadzidimitriou A, Sutton L, Bosch F, Laoutaris N, Anagnostopoulos A, Montserrat E, Fassas A, Dighiero G, Caligaris-Cappio F, Merle-Beral H, Ghia P, Davi F. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007; 109: 259-70.
5. Ghia P, Stamatopoulos K, Belessi Ch, Moreno C, Stella S, Guida G, Michel A, Crespo M, Laoutaris N, Davi F. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005; 105: 1678-85.
6. Tobin G, Thunberg U, Johnson A, Rosenquist R. Somatically mutated V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 2262-4.
7. Tobin G, Thunberg U, Karlsson K, Murray F, Laurell A, Willander K, Enblad G, Merup M, Vilpo J, Rosenquist R. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104: 2879-85.
8. Hamblin TJ, Davis Z, Garddiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-54.
9. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-7.
10. Lin K, Manocha S, Harris RJ, Matrai Z, Sherrington PD, Pettitt AR. High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using VH3-21 gene segment. Blood 2003; 102: 1145-6.
11. Philippe J, Janssens A, Smits K. Prognostic value of specific VH-genes in CLL. Leuk Lymphoma 2003; 44: 40.
12. Bomben R, Dal BoM, Capello D, Benedetti D, Marconi D, Zucchetto A, Forconi F, Maffei R, Ghia EM, Laurenti L, Bulian P, Del Principe MI, Palermo G, Thorselius M, Degan M, Campanini R, Guarini A, Del Poeta G, Rosenquist R, Efremov DG, Marasca R, Foa R, Caidano G, Gattei V. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood 2007; 109: 2989-98.
13. Rai KR, Sawitzky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-24.
14. Binet JL, Auguier A, Dighiero G, Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariante survival analysis. Cancer 1981; 48: 198-205.
15. International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989; 110: 236-8.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162: 156-9.
17. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Macintyre EA. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptorgene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257-317.
18. Lefranc MP. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 200; 29: 207-14.
19. Souto-Carneiro MM, Longo NS, Russ DE, Sun H.-W, Lipsky PE. Characterization of the human Ig heavy chain antigen binding complementary determining region 3 using a newly developed software algorithm, JOINSOLVER. J Immunol 2004; 172: 6790-802.
20. Messmer BT, Albesiano E, Efremov DG, Gjiotto F, Allen SL, Kolitz J, Foa R, Damle RN, Chiorazzi N. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200: 519-25.
21. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciquerra VP, Rai K, Chiorazzi N. Chronic lymphocytic leukemia B cells express restricted set of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 1515-25.
22. Widhopf GF, Rassenti II LZ, Toy TL, Gribben JG, Wierda WG, Kipps ThJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004; 104: 2499-504.
23. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE, Corcoran MM, Chapman RM, Thomas PW, Copplestone JA, Orchard JA, Hamblin TJ. Multivariate analysis of prognostic factors in CLL: clinical stage. IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177-84.